RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Advertising and Promotion of In Vitro Diagnostic Products

Advertising and Promotion of In Vitro Diagnostic Products

Posted 01 May 2011 | By Seth Mailhot, JD

The laws and regulations governing the advertising and promotion of in vitro diagnostic (IVD) devices are complex. Various regulatory agencies and entities share overlapping authority over IVDs, and, therefore, a substantial amount of regulatory understanding is required to effectively navigate the systems. The risks of noncompliance with regulatory requirements are significant, as shown by the $262 million civil False Claims Act settlement paid by Quest Diagnostics in 2009.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.